Literature DB >> 18512116

Relapse of chronic myeloid leukemia-chronic phase 14 years after allogeneic hematopoietic stem cell transplantation.

Daigo Akahane1, Yoshikazu Ito1, Masahiko Sumi1, Tetsuzo Tauchi1, Yukihiko Kimura1, Kazuma Ohyashiki2.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18512116     DOI： 10.1007/s12185-008-0092-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

1.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.

Authors:  Catriona H M Jamieson; Laurie E Ailles; Scott J Dylla; Manja Muijtjens; Carol Jones; James L Zehnder; Jason Gotlib; Kevin Li; Markus G Manz; Armand Keating; Charles L Sawyers; Irving L Weissman
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

Review 2.  Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?

Authors:  John Goldman; Myrtle Gordon
Journal:  Leuk Lymphoma       Date:  2006-01

3.  A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors.

Authors:  M Robin; P Guardiola; A Devergie; M Yeshurun; S Shapiro; H Esperou; P Ribaud; V Rocha; E Gluckman; G Socié
Journal:  Leukemia       Date:  2005-09       Impact factor: 11.528

4.  Rapid clonal development in a relapsed CML 11 years post replete allogeneic bone marrow transplantation.

Authors:  P Kearney; M Suter; J C Biggs
Journal:  Leuk Res       Date:  2002-01       Impact factor: 3.156

5.  Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.

Authors:  G Socié; R A Clift; D Blaise; A Devergie; O Ringden; P J Martin; M Remberger; H J Deeg; T Ruutu; M Michallet; K M Sullivan; S Chevret
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

6.  Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantation.

Authors:  A S Yong; J M Goldman
Journal:  Bone Marrow Transplant       Date:  1999-04       Impact factor: 5.483

7.  The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation.

Authors:  J P Radich; T Gooley; E Bryant; T Chauncey; R Clift; L Beppu; S Edmands; M E Flowers; K Kerkof; R Nelson; F R Appelbaum
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

8.  Graft-versus-leukemia reactions after bone marrow transplantation.

Authors:  M M Horowitz; R P Gale; P M Sondel; J M Goldman; J Kersey; H J Kolb; A A Rimm; O Ringdén; C Rozman; B Speck
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

9.  Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia.

Authors:  F van Rhee; F Lin; N C Cross; C D Reid; A K Lakhani; R M Szydlo; J M Goldman
Journal:  Bone Marrow Transplant       Date:  1994-10       Impact factor: 5.483
  9 in total
  1 in total

1.  Recent advances in the path toward the cure for chronic myeloid leukemia.

Authors:  Dong-Wook Kim
Journal:  Korean J Hematol       Date:  2011-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.